UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058033
Receipt number R000066054
Scientific Title The Effect of a Pamphlet Intervention for Surrogate Decision-Makers in Critical Care on Post-Intensive Care Syndrome-Family (PICS-F): A Non-Randomized Controlled Trial
Date of disclosure of the study information 2025/05/31
Last modified on 2025/05/31 15:21:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Impact of Pamphlet-Based Information for Families of ICU Patients on Their Psychological Burden

Acronym

ICU Family Pamphlet Study

Scientific Title

The Effect of a Pamphlet Intervention for Surrogate Decision-Makers in Critical Care on Post-Intensive Care Syndrome-Family (PICS-F): A Non-Randomized Controlled Trial

Scientific Title:Acronym

PICS-F Pamphlet Study

Region

Japan


Condition

Condition

Post-intensive Care Syndrome-Family (PICS-F)

Classification by specialty

Nursing Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to implement a pamphlet-based nursing intervention, designed to provide appropriate information and psychological support from before ICU discharge, for surrogate decision-makers (family members, etc.) of patients admitted to the ICU in the critical care setting, and to clarify the impact of this intervention on the prevention and reduction of Post-intensive Care Syndrome-Family (PICS-F).

Basic objectives2

Others

Basic objectives -Others

To investigate whether the pamphlet intervention used in this study is effective in preventing and reducing Post-intensive Care Syndrome-Family (PICS-F) in surrogate decision-makers in the critical care setting.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Presence of psychological distress in surrogate decision-makers at 3 months after ICU discharge (defined as IES-R score >=25, HADS-Anxiety subscale score >=8, or HADS-Depression subscale score >=8).

Key secondary outcomes

Anxiety symptoms (HADS-Anxiety) in surrogate decision-makers at 1 week after ICU discharge.
Depressive symptoms (HADS-Depression) in surrogate decision-makers at 1 week after ICU discharge.
Anxiety symptoms (HADS-Anxiety) in surrogate decision-makers at 3 months after ICU discharge.
Depressive symptoms (HADS-Depression) in surrogate decision-makers at 3 months after ICU discharge.
PTSD symptoms (IES-R) in surrogate decision-makers at 3 months after ICU discharge.
Frequency of pamphlet use, time spent using pamphlet, sections used, understanding of each section, usefulness in specific situations, and specific situations of use (pamphlet group only, at 3 months after ICU discharge).
Patient data (diagnosis, emergency admission, APACHE II score on ICU admission, length of ICU stay, surgery, mechanical ventilation, patient outcome, content of surrogate decision).


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

Participants: Surrogate decision-makers (family members, etc.) of patients admitted to the ICU in a critical care setting.
Intervention: In addition to standard nursing support for surrogate decision-making (verbal explanation), nurses will provide an explanation using an informational pamphlet on PICS-F prevention and coping (Contents: 1. About the ICU, 2. About decision-making, 3. Role of surrogate decision-makers, 4. About end-of-life care, 5. About family care support).
Timing/Frequency: Once when the family makes a surrogate decision.
Duration: Approximately 10-15 minutes.

Interventions/Control_2

Participants: Surrogate decision-makers (family members, etc.) of patients admitted to the ICU in a critical care setting.
Intervention: Standard nursing support for surrogate decision-making (verbal explanation) as routinely practiced at each participating facility. No pamphlet will be used.
Timing/Frequency: Provided as appropriate as part of usual care before the patient's ICU discharge.
Duration: Within the scope of usual care.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Provided written informed consent to participate in the study.
Family members who have made surrogate decisions regarding treatment (including choices about life-sustaining treatment) for patients admitted to an E-ICU or general ICU with an expected ICU stay of 48 hours or more.
Able to communicate in Japanese.
Aged 18 to 85 years.

Key exclusion criteria

Known history of psychiatric illness in the surrogate decision-maker.
Expected ICU stay for the patient is less than 24 hours.
Surrogate decision-maker has had ICU experience (as a surrogate) within the past 6 months.
Already enrolled as an intervention subject in this study (to prevent duplication).
Attending physician judges the surrogate decision-maker not to be in a suitable physical or mental state to participate in the study.
Otherwise deemed unsuitable for participation by the principal investigator (or co-investigator).

Target sample size

180


Research contact person

Name of lead principal investigator

1st name Fumiya
Middle name
Last name Kanaya

Organization

Social Medical Corporation Foundation Chiyukai Shin Yukuhashi Hospital

Division name

Department of Nursing

Zip code

824-0026

Address

1411 Dojoji, Yukuhashi-shi, Fukuoka, Japan

TEL

+81-930-24-8899

Email

shinyukuhashi.kanaya@gmail.com


Public contact

Name of contact person

1st name Fumiya
Middle name
Last name Kanaya

Organization

Social Medical Corporation Foundation Chiyukai Shin Yukuhashi Hospital

Division name

Department of Nursing

Zip code

824-0026

Address

1411 Dojoji, Yukuhashi-shi, Fukuoka, Japan

TEL

+81-930-24-8899

Homepage URL


Email

shinyukuhashi.kanaya@gmail.com


Sponsor or person

Institute

Social Medical Corporation Foundation Chiyukai Shin Yukuhashi Hospital
Department of Nursing
Fumiya Kanaya

Institute

Department

Personal name



Funding Source

Organization

KIMURA FOUNDATION FOR NURSING EDUCATION

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor

Japanese Red Cross Wakayama Medical Center
Matsuyama Municipal Hospital, Eiraikai General Incorporated Association
Maizuru Kyosai Hospital, Federation of National Public Service Personnel Mutual Aid Associations

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Social Medical Corporation Foundation Chiyukai Shin Yukuhashi Hospital

Address

1411 Dojoji, Yukuhashi-shi, Fukuoka, Japan

Tel

0930-58-5566

Email

pt-ikeda@waltz.ocn.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本赤十字社 和歌山医療センター
一般社団法人永頼会 松山市民病院
国家公務員共済組合連合会 舞鶴共済病院


Other administrative information

Date of disclosure of the study information

2025 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 05 Month 11 Day

Date of IRB


Anticipated trial start date

2025 Year 06 Month 01 Day

Last follow-up date

2026 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 05 Month 31 Day

Last modified on

2025 Year 05 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066054